UnknownNot Applicable

Intravascular Clotting (POCUS) - Marker of the Timing and Severity of Cardiac Arrest; Indicator of Futile Resuscitation

Poland40 participantsStarted 2024-04-29

Plain-language summary

The scientific goals of the project: 1. ultrasound assessment of the incidence of clotting in deep veins in patients after cardiac arrest during resuscitation and after the declaration of death; comparison to the incidence of clotting in the heart cavities 2. comparison of resuscitation results in patients with and without clotting detected in deep veins during resuscitation 3. determining the time from cardiac arrest to the occurrence of clotting in deep veins; comparison to the time until clotting occurs in the heart cavities Confirmation of the usefulness of the ultrasound-detected clotting in deep veins during resuscitation in assessing the severity of cardiac arrest and the prognosis of resuscitation, which is the aim of the project, will have an impact on international guidelines for determining the prognosis and potential futility of resuscitation.

Who can participate

Age range

18 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * patients who experience cardiac arrest in the emergency department, regardless of the mechanism and cause * patients who were declared dead after resuscitation after cardiac arrest that occurred in the emergency department Exclusion Criteria: * age under 18 years

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

Intravascular clotting during CPR

Timeframe: One year (preliminary data will be presented after 6 months.

Intravascular clotting after termination of CPR

Timeframe: One year (preliminary data will be presented after 6 months.

Time from cardiac arrest to first clot during CPR

Timeframe: One year (preliminary data will be presented after 6 months.

Time from cardiac arrest to first clot after termination of CPR.

Timeframe: One year (preliminary data will be presented after 6 months.

Trial details

NCT IDNCT06406920

SponsorMedical University of Gdansk

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2024-10-01

Contact for this trial

Robert K Szymczak, Asst. Prof.

0048667674141 robert.szymczak@gumed.edu.pl

View on ClinicalTrials.gov More Cardiac Arrest trials

Plain-language summary

Who can participate

Age range

18 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

What they're measuring

Intravascular clotting during CPR

Timeframe: One year (preliminary data will be presented after 6 months.

Intravascular clotting after termination of CPR

Timeframe: One year (preliminary data will be presented after 6 months.

Time from cardiac arrest to first clot during CPR

Timeframe: One year (preliminary data will be presented after 6 months.

Time from cardiac arrest to first clot after termination of CPR.

Timeframe: One year (preliminary data will be presented after 6 months.